An ultrastructural study of the macrophages of the carrageenan-induced granuloma in the rat lung.
The intralobular injection of 0.17 ml of 2 per cent. carrageenan into the rat lung induced an inflammatory granulomatous response. This inflammation was characterized in the early stages by immediate polymorphonuclear (PMN) leucocyte infiltration into the alveoli. Within 2 days the PMN's began to disappear and were replaced by carrageenan-containing macrophages. Alveolar macrophages actively phagocytised the injected carrageenan and were the dominant cell type in he alveoli for the length of this study (365 days). These low-turnover alveolar macrophages, which with light microscopy stained pinkish-red metachromatically with toludine blue due to their carrageenan content, underwent changes in vacuole morphology as well as changes in size and shape. Throughout the course of this inflammation, these macrophages had carrageenan-containing vacuoles which could be seen undergoing fusion to form larger vacuoles which at times constituted half the size of the entire macrophage cytoplasm. The carrageenan in the vacuoles was an amorphous flocculent appearing material for the initial 14 days but changes to a more fine filamentous form for the remainder of the study. This was probably due to its partial digestion by lysosomal enzymes. The general composition of the cytoplasm remained fairly constant during the 365 days. Pinocytotic vesicles and free ribosomes were abundant and the many mitochondria were small and rounded. Smooth endoplasmic reticulum lysosomes, and Golgi apparati, although not prominent, were present but the most striking feature of the cytoplasm was the presence of numerous lamellar bodies (phagocytosised surfactant). Some of the macrophages increased greatly in overall size (five to seven times) compared to their initial size. A few isolated macrophages could be seen degenerating but no general necrosis was seen. Except for one isolated case, no epithelioid cells were observed in this carrageenan inflammation. Fibrosis, if present at all, was very localised and was only evident at day 340 post-injection. This fibrosis generally involved one or two carrageenan-containing macrophages encapsulated by a few collagen fibres. No widespread fibrosis was ever observed in this study which confirmed earlier histological and biochemical investigations.
D000818:Animals; D002351:Carrageenan; D006099:Granuloma / Q000139:chemically induced / Q000473:pathology*; D008171:Lung Diseases / Q000139:chemically induced / Q000473:pathology*; D008264:Macrophages / Q000648:ultrastructure*; D008297:Male; D008854:Microscopy, Electron; D011650:Pulmonary Alveoli / Q000648:ultrastructure; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014617:Vacuoles / Q000648:ultrastructure
D002351:Carrageenan